MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611024510 A) filed by Chandigarh University, Mohali, Punjab, on March 2, for 'iot-based post-ingestion physiological verification system for medication adherence.'
Inventor(s) include Yash.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a non-invasive, IoT-based post-ingestion physiological verification system for monitoring medication adherence and therapeutic effectiveness. The system integrates an IoT-enabled smart pillbox for detecting medication ingestion events with wearable physiological sensors configured to monitor vital parameters within a predefined post-ingestion time window. Physiological data collected from the wearable device is synchronized with ingestion events and analyzed using artificial intelligence and machine learning models that predict medication-specific physiological response patterns. A decision engine compares observed responses with expected outcomes to verify true medication adherence and detect non-adherence or non-response conditions. Real-time alerts are generated for patients, caregivers, and healthcare professionals when deviations are identified. All ingestion and physiological response data is securely stored in cloud-based or electronic health record systems, enabling long-term adherence tracking, clinical analytics, and personalized treatment optimization."
Disclaimer: Curated by HT Syndication.
